Cargando…

Reactive Arthritis After COVID-19: A Case Report

A 43-year-old healthy male was diagnosed with symptomatic COVID-19. Soon after recovery, he experienced severe back pain, bilateral red eye, and a new penile lesion. He was diagnosed with reactive arthritis, given he presented with arthritis, conjunctivitis, and balanitis. The patient was treated wi...

Descripción completa

Detalles Bibliográficos
Autor principal: Basheikh, Mohammed
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Cureus 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9106556/
https://www.ncbi.nlm.nih.gov/pubmed/35573487
http://dx.doi.org/10.7759/cureus.24096
_version_ 1784708314683146240
author Basheikh, Mohammed
author_facet Basheikh, Mohammed
author_sort Basheikh, Mohammed
collection PubMed
description A 43-year-old healthy male was diagnosed with symptomatic COVID-19. Soon after recovery, he experienced severe back pain, bilateral red eye, and a new penile lesion. He was diagnosed with reactive arthritis, given he presented with arthritis, conjunctivitis, and balanitis. The patient was treated with nonsteroidal anti-inflammatory drugs (NSAIDs), a short course of systemic steroids, and a local steroid cream on the penile lesion, followed by a local antifungal cream for two months. The patient responded well to the treatment and returned to his usual life activities.
format Online
Article
Text
id pubmed-9106556
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Cureus
record_format MEDLINE/PubMed
spelling pubmed-91065562022-05-14 Reactive Arthritis After COVID-19: A Case Report Basheikh, Mohammed Cureus Internal Medicine A 43-year-old healthy male was diagnosed with symptomatic COVID-19. Soon after recovery, he experienced severe back pain, bilateral red eye, and a new penile lesion. He was diagnosed with reactive arthritis, given he presented with arthritis, conjunctivitis, and balanitis. The patient was treated with nonsteroidal anti-inflammatory drugs (NSAIDs), a short course of systemic steroids, and a local steroid cream on the penile lesion, followed by a local antifungal cream for two months. The patient responded well to the treatment and returned to his usual life activities. Cureus 2022-04-13 /pmc/articles/PMC9106556/ /pubmed/35573487 http://dx.doi.org/10.7759/cureus.24096 Text en Copyright © 2022, Basheikh et al. https://creativecommons.org/licenses/by/3.0/This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
spellingShingle Internal Medicine
Basheikh, Mohammed
Reactive Arthritis After COVID-19: A Case Report
title Reactive Arthritis After COVID-19: A Case Report
title_full Reactive Arthritis After COVID-19: A Case Report
title_fullStr Reactive Arthritis After COVID-19: A Case Report
title_full_unstemmed Reactive Arthritis After COVID-19: A Case Report
title_short Reactive Arthritis After COVID-19: A Case Report
title_sort reactive arthritis after covid-19: a case report
topic Internal Medicine
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9106556/
https://www.ncbi.nlm.nih.gov/pubmed/35573487
http://dx.doi.org/10.7759/cureus.24096
work_keys_str_mv AT basheikhmohammed reactivearthritisaftercovid19acasereport